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ABSTRACT 
Objectives: To explore and compare levels of mental health, care burden and relationship 
satisfaction among caregiving spouses of people with mild cognitive impairment or 
dementia in Parkinson disease (PD-MCI or PDD), or dementia with Lewy bodies (DLB). 
Methods: Spouses (n = 136) completed measures of mood, stress, resilience, general health, 
quality of life, care burden, and relationship satisfaction, as well as socio-demographic 
factors. Additionally, data on motor and neuropsychiatric symptom severity of people with 
PD-MCI, PDD or DLB was obtained in a sub-sample. 
Results: Most spouses were married women (> 85%) who provided a median of 4 years of 
care and 84 hours of weekly care. Among these, relationship dissatisfaction, stress, anxiety, 
care burden, and feelings of resentment were common. Spouses of people with PDD and 
DLB had significantly higher rates of burden, resentment and depression compared to 
spouses of people with PD-MCI. Furthermore, unique group differences emerged whereby 
spouses of people with PDD had significantly longer duration of care provision, higher 
stress, more relationship dissatisfaction, and fewer positive interactions, compared to PD-
MCI group, whereas anxiety and lower levels of mental health were prominent in spouses of 
people with DLB, compared to PD-MCI group. Despite this, the majority of spouses reported 
good quality of life, resilience, and satisfaction with the caring role.  
Conclusion: PDD and DLB significantly contribute to poorer mental health and higher levels 
of care burden in spouses. Clinicians should actively screen the risk of burden, stress, 
depression and anxiety among caregiving spouses of people with these conditions.  
Keywords: informal caregiving; spouses; Parkinson disease dementia (PDD); dementia with 
Lewy bodies (DLB); Parkinson disease and mild cognitive impairment (PD-MCI); burden 
Word count: 4464 (excluding abstract, tables, in-text references and reference list) 
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INTRODUCTION 
 
Worldwide approximately 10 million people have Parkinson disease1 and 47 million people 
have dementia2, of whom majority are cared by spouses and long-term partners. The 
characteristics of carers of people with Parkinson disease (PD) and non-PD dementias have 
already been well described.3 However, there is little understanding of the characteristics of 
caregiving spouses in the context of mild cognitive impairment or dementia in PD (PD-MCI 
or PDD), or in dementia with Lewy bodies (DLB). A deeper understanding of the emotional, 
psychological and relationship patterns of carers of people with these conditions is crucial 
so that the care and quality of life of those with PD-MCI, PDD and DLB can be optimised. 
 
PD is a complex movement disorder which is characterised by a myriad of motor and non-
motor symptoms, including neuropsychiatric and cognitive abnormalities, autonomic 
dysfunction, sleep disturbances and sensory abnormalities.4-5 As the motor and non-motor 
symptoms are common amongst people with PD, Langston (2006)6 highlighted that 
parkinsonism is just ‘tip of the iceberg’ and should rather be seen as the ‘Parkinson’s 
complex’. Approximately 25% of people with PD present with MCI at the point of PD 
diagnosis7. PD-MCI is characterised by impairment in at least two cognitive domains, but 
which is not severe enough to significantly impact on an individual’s functional ability.7 Up 
to 80% of people develop dementia in PD (PDD) within 10 to 20 years following the onset of 
motor symptoms.8,9 PDD is diagnosed when cognitive impairments are severe enough to 
affect functional ability, and PDD is associated with a significant drop in quality of life, an 
increase in level of disability and carer burden.10 The prevalence of PDD is predicted to rise 
threefold by 2060,11 underscoring the need to recognise and manage this stage of PD in an 
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optimal way. DLB is the second most common type of dementia12 and often presents with 
cognitive changes before, or simultaneously with, typical parkinsonian motor changes. DLB 
is characterised by fluctuating levels of consciousness, frequent visual hallucinations, and an 
array of other neuropsychiatric symptoms.13,14 PD-MCI, PDD and DLB are all part of the Lewy 
body spectrum of disorders, and while PDD and DLB share many underlying pathological 
changes and certain cognitive and neuropsychiatric features, their course and prognosis 
may differ.12,15-18 Thus, comparing and contrasting key aspects of these clinical 
presentations, such as the impact on spousal carers, is important.  
 
PD-MCI, PDD and DLB are all progressive neurodegenerative conditions characterised by 
cognitive, neuropsychiatric and motor changes. As these conditions progress, the support of 
a carer becomes necessary, and this role is most frequently filled by spouses or life partners, 
adult children or other family members. Carers are important in supporting disease 
management and activities of daily living of people with PD-MCI, PDD or DLB; however, 
providing care may lead to challenges in balancing personal and care-related 
responsibilities, and may increase burden and stress.19–25 Providing care may also result in 
depression and anxiety in carers.22,26 With the progression of cognitive impairment in PD 
and DLB, burden9,23,27–30 and emotional stress31–33 intensify in carers, and their quality of life 
drops.9,34 This suggests that the stage of cognitive impairment in the care recipient 
significantly affects carer well-being. Consequently, caring may lead to neglect of carers’ 
own health and needs,35,36 carer burnout,24 and institutionalisation of care recipients,11,37–41 
all of which have long-term cost implications. 
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Studies have explored the impact of PD without cognitive impairment to PD-MCI and PDD9,34 
on carer burden and quality of life, but earlier studies did not include carers of people with 
DLB. Thus, the current study aimed to describe and compare the sociodemographic and 
clinical characteristics of caregiving spouses according to the clinical syndrome of care 
recipients (i.e. PD-MCI, PDD or DLB). We hypothesized that, since the rate of decline and 
neuropsychiatric burden of people with DLB may be greater than in PD-MCI or PDD, the 
spouses of people with DLB would experience higher levels of mental health problems, care 
burden and relationship dissatisfaction. 
 
METHODS 
Sample and setting 
This cross-sectional study was nested within the INVEST (INdiVidualised cognitivE 
Stimulation Therapy) study. INVEST is a pilot feasibility randomised controlled trial of 
individualised cognitive stimulation therapy adapted for people with PD-MCI, PDD or DLB 
(‘CST-PD’), and their study partners.42 Participants were eligible if they were a caregiving 
spouse of a person with PD-MCI, PDD, or DLB. We applied the term ‘spouse’ in a broad 
sense to include married partners as well as ‘life partners’ or people who lived with the 
person PD-MCI, PDD or DLB in an intimate way. Individuals who were in a non-intimate 
relationship with the person with PD-MCI, PDD or DLB, whose spouse with one of these 
conditions had passed away, or who lacked capacity to consent were excluded from the 
study. 
 
Recruitment and procedure 
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We recruited the spouses of people with PD-MCI, PDD OR DLB via two routes: (1) baseline 
assessments in the INVEST study undertaken in a home-based interview between the 
researcher and the couple (April 2016 – July 2017), and (2) a postal questionnaire for 
spouses only (July 2017 – January 2018). 
 
In route one, participant-dyads for the INVEST study were identified through memory or 
movement disorder clinics in four locations in England (Greater Manchester, Derbyshire, 
North East London and Warrington). People with PD-MCI, PDD and DLB were diagnosed by 
the referring PD specialists who were geriatricians, neurologists, and PD specialist nurses 
with expertise in the diagnosis and management of PD and working in movement disorder 
clinics. They all followed accepted diagnostic criteria for possible or probable PD-
MCI43/PDD44 and DLB45, and undertook validated cognitive screening tests (i.e. such as the 
Addenbrooke’s Cognitive Evaluation rating scale)46 to ascertain the presence of dementia or 
MCI. In some cases, neuroimaging (i.e. dopamine transporter SPECT imaging or ‘DaT scan’) 
was used by the referrers to support the diagnosis. Following referral, we screened 
participants at their first visit using the Montreal Cognitive Assessment (MOCA)47 to verify 
and document the extent of cognitive impairment, as well as taking a history to verify the 
referral diagnosis as PD-MCI or PDD or DLB. 
 
In route two, potential participants for the postal questionnaire study were identified 
through: (a) the ‘screen-failed’ participant list of the INVEST study, who were unable to 
participate in the INVEST study due to distance from the research centre, high presence of 
care burden or lack of interest in participating in an interventional study; and (b) patient 
databases held by the Greater Manchester Mental Health and North West Boroughs 
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Healthcare National Health Service (NHS) Trusts. In this route, spouses self-reported the 
diagnosis of the care recipient. As majority of spouses in the postal questionnaire were 
recruited via the INVEST screen-failed list and NHS patient databases, the diagnosis of care 
recipients could be verified and it was therefore not considered a major concern of the 
study. The postal questionnaire, together with an invitation letter, a participant information 
sheet, a consent form and a pre-paid envelope were posted out to potential participants. 
We also utilised UK-based charity and research websites (e.g. Parkinson’s UK, Join Dementia 
Research, the UK’s Lewy Body Society) as recruitment methods for route one and two. 
 
The data of 57 spouses were extracted from the INVEST study, which represented all those 
eligible from this dataset. Additionally, 79 spouses participated in the postal questionnaire 
study. People with PD-MCI, PDD or DLB did not participate in the current study. 
 
Ethics 
The INVEST study and the postal questionnaire received ethical approval from the Yorkshire 
& The Humber – Bradford Leeds Research Ethics Committee (reference number: 
15/YH/0531). All spouses who were eligible to participate in the study provided written 
informed consent. Additionally, people with PD-MCI, PDD or DLB recruited via route 1 
provided written informed consent through the INVEST study and all had the capacity to 
consent to participation. 
 
 
Measures 
To gain a comprehensive overview of the emotional, psychological and relationship factors 
among caregiving spouses of the three groups, we administered a battery of validated rating 
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scales, several of which are novel in this population. The included scales are described 
below. 
 
Burden, stress and resilience: The Zarit Burden Interview (ZBI)48, a 22-item scale, assesses 
spouses’ degree of burden on a 5-point Likert scale (0 = never to 4 = nearly always). The 
Relatives’ Stress Scale (Rel.SS)49 consists of 15 items on a 5-point scale from 0 (never/not at 
all) to 4 (always/considerably), measuring the amount of stress and upset experienced by 
the spouse as a result of providing care. The Dyadic Relationship Scale (DRS)50 assesses 
positive interaction (6 items) and negative strain (5 items) with the care recipient on a 4-
point Likert scale ranging from 0 (strongly disagree) to 3 (strongly agree). The Family 
Caregiving Role scale (FCR)51 consists of 16 items on a 5-point Likert scale (1 = strongly 
disagree to 5 = strongly agree), which are divided into 3 sub-scales: (1) satisfaction with the 
caring role, (2) resentment and (3) anger. The Brief Resilience Scale (BRS)52 explores the 
ability to bounce back from stress with 6 items on a 5-point Likert scale varying from 1 
(strongly disagree) to 5 (strongly agree). Higher scores on the ZBI, Rel.SS, DRS-negative 
strain, FCR-resentment and FCR-anger indicate higher levels of burden, stress, strain and 
negative feelings, whereas higher scores on DRS-positive interaction, FCR-satisfaction and 
BRS show greater positive interaction, satisfaction with the caring role and higher resilience. 
 
Relationship satisfaction: The Relationship Satisfaction Scale (RSS)53 explores relationship 
satisfaction with regards to communication and openness, conflict resolution, degree of 
affection/caring, intimacy/closeness, as well as overall satisfaction with the relationship 
with 7 items on a 7-point Likert scale (0 = very dissatisfied to 6 = very satisfied). Higher score 
on the RSS indicate higher relationship satisfaction. 
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Health and quality of life: The Short Form 12 Health Survey (SF-12)54 evaluates spouses’ 
physical and mental health separately in 12 yes/no or Likert-type questions. The Hospital 
Anxiety and Depression Scale (HADS)55 consists of 14 items measuring anxiety and 
depression on a 4-point Likert scale ranging between 0 and 3. The EuroQoL-5D-3L (EQ-5D)56 
assesses health-related quality of life with an index score consisting of five indices (i.e. 
mobility, self-care, usual activities, pain/discomfort, anxiety/depression), and a visual 
analogue scale (VAS) rating spouses’ health today on a scale between 0 and 100%. Higher 
scores on the SF-12 and the EQ-5D indicate better physical/mental well-being and quality of 
life, whereas higher scores on the HADS indicate higher anxiety/depression. 
 
PD-related symptoms (elicited from the home-based assessments in route 1): The Hoehn 
and Yahr stage (H&Y)57 (range I to V) and Unified Parkinson’s disease Rating Scale part III 
(UPDRS-III)58 (range 0 to 100) measure the severity of care recipients’ PD. The Schwab & 
England Activities of Daily Living scale (SE-ADL)59 (range 0 to 100%) assesses care recipients’ 
functional ability. The MoCA47 evaluates the cognitive status of the person with PD-MCI, 
PDD OR DLB, which can range between 0 and 30, and the Neuropsychiatric Inventory (NPI)60 
measures the frequency and severity of 12 neuropsychiatric symptoms of the care 
recipients, which were rated by spouses. For H&Y, UPDRS-III and NPI, higher scores indicate 
a more advanced disease stage and more frequent and severe neuropsychiatric symptoms.  
 
Demographic information: Age, gender, education, ethnicity, marital status, relationship 
duration and living status were collected about both partners. In addition, spouses provided 
details of care recipients’ diagnosis, year of onset of PD or DLB symptoms and degree of 
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cognitive impairment as well as regarding spouses’ duration of care provision in years and 
weekly hours. 
 
Several scales of this study, such as the ZBI, Rel.SS, SF-12, EQ-5D, HADS, have been widely 
used with carers and spouses of people with PD-MCI, PDD, DLB; however, the remaining 
scales (i.e. RSS, DRS, BRS; FCR) appear to be novel in this population and their psychometric 
properties in this sample are described elsewhere (Vatter et al., in submission). 
 
Analyses 
Descriptive variables are presented as percentages (categorical variables), means and 
standard deviations [SD] (normally distributed continuous variables), or medians and 
interquartile ranges [IQR] (non-normally distributed continuous variables). Parametric tests 
(i.e. t-test, ANOVA) and non-parametric tests (i.e. Spearman correlation coefficient, Mann-
Whitney U-test and Kruskal-Wallis H test) were undertaken, as appropriate. Due to the use 
of several tests and several groups, post hoc tests (i.e. Bonferroni, Hochberg or Games-
Howell) were applied. Missing data were imputed with the expectation-maximization 
method. Outliers were transformed with winsorization, whereby the outliers were assigned 
the highest or the lowest value found in the sample that was not an outlier. All analyses 
were conducted in SPSS version 23 and the significance level for the results was set at p < 
.05. 
 
RESULTS 
Sample characteristics 
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Participants were spouses of people with PD-MCI, PDD or DLB (n = 136), all of whom lived 
together with the care recipient. Most participants (94.9%) were married (Table 1). The 
median relationship duration was 46.5 years (IQR = 34.75, 53.00). The majority of couples 
comprised a male with PD-MCI, PDD or DLB and a female spouse (85.3%) and most were 
white British. The mean age of spouses was 69.44 years (SD = 7.62) and of care recipients, 
73.51 years (SD = 6.48). Thirty-seven people had a diagnosis of PD-MCI, 50 of PDD and 49 of 
DLB. The median disease duration of PD (including DLB diagnosis in the absence of PD 
diagnosis) was 5 years (IQR = 3, 10) and of cognitive impairment, 4 years (IQR = 2, 6). The 
median duration of PD and cognitive impairment amongst people with PD-MCI was 6 (IQR = 
3.00, 7.64) years and 3 (IQR = 1.00, 5.00) years, respectively; amongst people with PDD 10 
(IQR = 5.00, 16.25) years and 4.5 (IQR = 2.00, 7.25) years, respectively, and amongst people 
with DLB 3 (IQR = 1.00, 5.50) years and 4 (IQR = 2.00, 6.00) years, respectively. Spouses had 
provided care for between 0 and 20 years (median = 4; IQR = 2, 7) and at the time of the 
study were providing between 0 and 168 hours of care per week (median = 84; IQR = 38.5, 
168). Nearly half of the spouses (46.0%) provided over 100 hours of care per week. The 
median care provision duration among spouses of people with PD-MCI was 4 (IQR = 2.00, 
7.00) years and 56 (IQR = 28.00, 168.00) weekly hours, among spouses of people with PDD 7 
(IQR = 3.00, 10.25) years and 126 (IQR = 42.00, 168.00) weekly hours, and among spouses of 
people with DLB 2.5 (IQR = 2.00, 6.00) years and 98 (IQR = 42.00, 168.00) weekly hours. In 
the sub-sample of care recipients recruited via Route 1, 50.9% had a H&Y stage of 2 (Table 
2). We have outlined the scores of the MoCA, UPDRS-III, SE-ADL and NPI, according to PD-
MCI, PDD or DLB grouping, in Table 2. 
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Table 1 Participant characteristics (n = 136 spouses) 
 Spouses People with PD-MCI,  
PDD or DLB 
Categorical variables, N (%)   
Gender, female 116 (85.3) 20 (14.7) 
Ethnicity, white British 122 (89.7) 123 (90.4) 
Relationship status 
     Married 
     Cohabiting 
 
129 (94.9) 
7 (5.1) 
 
Living  with spouse 136 (100)  
Education 
     Left school aged 14-16 years 
     Left school aged 17-18 years 
     Further education 
     Higher education (university degree) 
 
41 (30.1) 
11 (8.1) 
34 (25.0) 
50 (36.8) 
 
54 (39.7) 
6 (4.4) 
36 (26.5) 
40 (29.4) 
Clinical diagnosis 
     PD-MCI 
     PDD 
     DLB 
 
 
 
37 (27.2) 
50 (36.8) 
49 (36.0) 
Continuous variables, Mean (SD); range  
Age, years 69.44 (7.62); 48-85 73.51 (6.48); 49-90 
Continuous variables, Median (IQR); range  
Relationship duration, years 46.5 (34.75, 53.00); 5-68  
Age left full-time education 17 (16.00,20.00); 14-53 16 (15.00, 20.75); 14-46 
Duration of PD, years  5 (3.00, 10.00); 0-37 
Duration of cognitive impairment, years  4 (2.00, 6.00); 0.2-22 
Care provision duration, years 4 (2.00, 7.75); 0-20  
Care provision hours/week 84 (38.50, 168.00); 0-168  
Abbreviations: DLB – Dementia with Lewy bodies; IQR – interquartile range; PD – Parkinson disease; PDD – 
Parkinson disease dementia; PD-MCI – Parkinson disease and mild cognitive impairment; SD – standard 
deviation. 
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Table 2 Disease variables of 57 care recipients 
   People with: 
 
 
Categorical variables, n (%) 
Spouses 
n = 57 
Care 
recipients 
n = 57 
PD-MCI 
n = 18 
PDD 
n = 25 
DLB 
n = 14 
Retired, ‘yes’ 47 (82.5) 57 (100)    
H&Y stage      
     I  9 (16.4)    
     II  28 (50.9)    
     III  6 (10.9)    
     IV  10 (18.2)    
     V  2 (3.6)    
Continuous variables, Median (IQR); range    
MoCA score (max 30)   22.00 (19.00, 
25.25); 13-30 
16.50 (13.00, 
21.00); 7-26 
17.00 (14.50, 
19.50); 8-24 
UPDRS-III (max 100)   20.00 (15.00, 
26.50); 10-47 
37.50 (23.75, 
41.50); 13-53 
35.00 (32.00, 
45.00); 10-58 
SE-ADL (max 100)   80.00 (50.00, 
90.00); 30-90 
40.00 (25.00, 
65.00); 20-90 
50.00 (27.50, 
60.00); 10-80 
NPI (max 120)   5.00 (2.00, 
11.50); 0-42 
14.00 (4.00-
24.00); 0-58 
12.00 (7.75, 
38.25); 0-53 
NPI – carer distress (max 50)   3.50 (1.50, 
6.00); 0-17 
6.00 (2.00, 
11.75); 0-31 
5 (3.50, 
14.50); 0-30 
Abbreviations: DLB – Dementia with Lewy bodies; H&Y – Hoehn & Yahr scale; IQR – interquartile range; MoCA 
– Montreal Cognitive Assessment; NPI – the Neuropsychiatric Inventory; PD – Parkinson disease; PDD – 
Parkinson disease dementia; PD-MCI – Parkinson disease and mild cognitive impairment; SD – standard 
deviation; SE-ADL – Schwab & England Activities of Daily Living scale; UPDRS-III – Unified Parkinson’s disease 
Rating Scale part III. 
 14 
 
Table 3 Participant measures (n = 136 spouses) 
Measures Mean (SD) n (%) 
RSS 24.97 (11.94)  
     Very dissatisfied (0-20)  18 (35.29) 
     Moderately dissatisfied (21-30)  31 (22.79) 
     Moderately satisfied (31-40)  36 (26.47) 
     Very satisfied (41-42)  18 (13.24) 
ZBI 36.83 (16.31)  
     Little or no burden (0-20)  19 (13.97) 
     Mild to moderate burden (21-40)  57 (41.91) 
     Moderate to severe burden (41-60)  41 (30.15) 
     Severe burden (61-88)  10 (7.35) 
BRS 3.52 (0.80)  
     Low resilience (1.00-2.99)  30 (22.06) 
     High resilience (3.00-5.00)  106 (77.94) 
HADS-anxiety 7.56 (4.54)  
     Normal (0-7)  68 (50.00) 
     Mild anxiety (8-10)  31 (22.79) 
     Moderate anxiety (11-14)  23 (16.91) 
     Severe anxiety (15-21)  12 (8.82) 
HADS-depression 5.78 (4.07)  
     Normal (0-7)  85 (62.50) 
     Mild depression (8-10)  33 (24.26) 
     Moderate depression (11-14)  13 (9.56) 
     Severe depression (15-21)  3 (2.21) 
SF-12-PCS 50.38 (10.80)  
SF-12-MCS 44.86 (10.50)  
EQ5D-Index 0.770 (0.236)  
     Low quality of life (-1.000…0.799)  69 (50.74) 
     High quality of life (0.800…+1.000)  67 (49.26) 
EQ5D-VAS 75.20 (17.30)  
     Low quality of life (0-79)  63 (46.32) 
     High quality of life (80-100)  71 (52.21) 
Rel.SS 25.74 (10.83)  
     Little or no stress (0-22)  52 (38.24) 
     Mild to moderate stress (23-29)  26 (19.12) 
     Moderate to severe stress (30-60)  55 (40.44) 
DRS-positive interaction 9.33 (3.25)  
DRS-negative strain 5.32 (3.37)  
FCR-satisfaction 4.04 (0.51)  
     Low satisfaction with caring role (1.00-2.49)  2 (1.47) 
     High satisfaction with caring role (2.50-5.00)  132 (97.06) 
FCR-resentment 2.77 (0.97)  
     Low feelings of resentment (1.00-2.49)  51 (37.50) 
     High feelings of resentment (2.50-5.00)  85 (62.50) 
FCR-anger 1.98 (0.83)  
     Low feelings of anger (1.00-2.49)  92 (67.65) 
     High feelings of anger (2.50-5.00)  43 (31.62) 
Abbreviations: BRS – Brief Resilience Scale; DRS – Dyadic Relationship Scale, positive interaction or negative strain sub-
scale; EQ-5D – EuroQoL-5D index; EQ5D VAS – EurQoL-5D visual analogue scale; FCR – Family Caregiving Role scale; HADS – 
Hospital Anxiety and Depression Scale; Rel.SS – Relatives’ Stress Scale; RSS – Relationship Satisfaction Scale; SD – standard 
deviation; SF-12 – Short Form 12 Health Survey, physical health (PCS) or mental health (MCS) sub-scale; ZBI – Zarit Burden 
Interview. 
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Characteristics of spouses 
 
In Table 1 we present the descriptive values of spouses’ characteristics and in Table 3 we 
outline the cut-off scores of each measure. In Tables 4 and 5 we report associations among 
spousal and care recipient variables, respectively, with the Spearman rank correlation 
analyses (with Bonferroni adjusted alpha levels of .003). A separate Spearman rank 
correlation analysis between the participants recruited via route one and route two was 
conducted which revealed no significant differences; thus, we only present merged data in 
Table 4. 
 
Burden, stress and resilience 
Nearly 60% of spouses experienced stress (n = 81; Rel.SS) and 36% burden (n = 49; ZBI); 
however, over 75% of respondents (n = 106) reported good resilience (BRS), highlighting 
that spouses could adapt well to stressful situations. A large proportion of spouses displayed 
resentment (n = 85; 62.50%; FCR-resentment) and a smaller proportion of the sample (n = 
43, 31.6%) reported feeling anger due to their caring role (FCR-anger). In contrast, nearly all 
(n = 132, 97.1%) reported feeling satisfied with their caring role (FCR-satisfaction). Burden 
(ZBI) significantly correlated with stress (Rel.SS), strain (DRS), depression (HADS), anxiety 
(HADS), mental health (SF-12), quality of life (EuroQoL), resilience (BRS), resentment and 
anger (FCR). 
 
Relationship satisfaction 
Almost 60% of participants (n = 79; RSS) were dissatisfied with the relationship. Lower 
relationship satisfaction (RSS) in spouses was associated with higher burden (ZBI), stress 
(Rel.SS), anxiety and depression (HADS), negative strain (DRS), feelings of resentment and 
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anger (FCR), and lower mental health (SF-12), quality of life (EuroQoL), lower resilience 
(BRS) and fewer positive interactions with one’s partner (DRS). 
 
Health and quality of life 
Clinically significant anxiety and depression was reported by 25.7% (n = 35) and 11.8% (n = 
16) of participants, respectively. About half of spouses reported relatively good quality of 
life according to the EQ-5D-index scores (n = 67, 49.3%) and visual analogue scale (n = 71, 
52.2%). Lower spouses’ mental health (SF-12) was related to intrapersonal aspects (i.e. own 
anxiety, depression, quality of life, resilience) as well as interpersonal aspects (i.e. burden, 
stress, strain, resentment and anger related to care provision). 
 
PD symptoms 
For the sub-sample of 57 spouses and people with PD-MCI, PDD OR DLB, Spearman rank 
correlation analyses were performed using a Bonferroni adjusted alpha level of .005 
(.05/10). The duration of caregiving years correlated with care recipients’ PD and cognitive 
impairment duration (both p < .001), H&Y stage (p = .001), SE-ADL (p < .001) and weekly 
care provision hours (p = .002), but not with UPDRDS-III (p = .109) (Table 4). There was also 
a significant negative association between weekly care provision hours and SE-ADL (p < 
.001), but this was not related to PD motor symptom severity. 
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Table 4 Spearman correlation analyses among spousal characteristics (n = 136 spouses) 
 RSS ZBI BRS HADS-
anx. 
HADS-
depr. 
SF-12-
PCS 
SF-12-
MCS 
EQ5D-
index 
EQ5D-
VAS 
Rel.SS DRS-
inter. 
DRS-
strain 
FCR-
satisf. 
FCR-
resent. 
ZBI -.712***              
BRS  .359*** -.487***             
HADS-Anxiety -.432***  .689*** -.594***            
HADS-Depression -.553***  .681*** -.547***  .760***           
SF-12-PCS  .030 -.019  .128 -.054 -.162          
SF-12-MCS  .494*** -.635***  .599*** -.742*** -.662*** -.157         
EQ5D-index  .281** -.286**  .350*** -.448*** -.468***  .597***  .345***        
EQ5D-VAS  .266** -.279**  .345*** -.374*** -.391***  .591***  .299***  .511***       
Rel.SS -.624***  .872*** -.505***  .672***  .694*** -.014 -.671*** -.387*** -.266**      
DRS-interaction  .351*** -.209  .122 -.126 -.177 -.093  .145  .096  .001 -.153     
DRS-strain -.636***  .710*** -.330***  .441***   .487***  .055 -.455*** -.225 -.272**  .639*** -.314***    
FCR-satisfaction  216 -.210  .077 -.042  -.103 -.121  .005 -.128 -.066 -.112  .387*** -.369***   
FCR-resentment -.612***  .752*** -.427***  .605***   .701***  .112 -.578*** -.258** -.184  .748*** -.201  .569*** -.123  
FCR-anger -.571***  .598*** -.320**  .464***   .383***  .102 -.463*** -.266** -.212  .584*** -.428***  .659*** -.346*** .546*** 
Notes: ** p < .003, *** p < .001 (Bonferroni adjustment applied) 
Abbreviations: BRS – Brief Resilience Scale; DRS – Dyadic Relationship Scale, positive interaction or negative strain sub-scale; EQ-5D – EuroQoL-5D index score or visual 
analogue scale (VAS); FCR – Family Caregiving Role scale, caregiving satisfaction, resentment or anger sub-scale; HADS – Hospital Anxiety and Depression Scale, anxiety or 
depression sub-scale; Rel.SS – Relatives’ Stress Scale; RSS – Relationship Satisfaction Scale; SF-12 – Short Form 12 Health Survey, physical health (PCS) or mental health 
(MCS) sub-scale; ZBI – Zarit Burden Interview. 
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Table 5 Spearman correlation analyses among Parkinson symptoms and care provision aspects (n = 57 couples) 
 Caring 
duration (y) 
Weekly 
caring (h) 
PD 
duration 
Cognitive 
impairment 
duration 
MoCA H&Y UPDRS-
III 
SE-ADL NPI-
total 
Weekly caring (h)  .261**         
PD duration  .673***  .236        
Cogn. Imp. Duration  .411***  .123  .309***       
MoCA  .081 -.264 -.028  .059      
H&Y  .449**  .284  .415**  .265 -.203     
UPDRS-III  .230  .328  .298  .165 -.298  .662***    
SE-ADL -.551*** -.443** -.340 -.361  .330 -.636*** -.657***   
NPI-total  .194  .314  .232  .297 -.029 .241 .300 -.359  
NPI-carer distress  .084  .175  .185  .164 -.055 .341 .349 -.236 .830*** 
Notes: ** p < .005, *** p < .001 
Abbreviations: H&Y – Hoehn & Yahr scale; MoCA – Montreal Cognitive Assessment; NPI – Neuropsychiatric Inventory; PD – Parkinson disease; SE-ADL – Schwab & England 
Activities of Daily Living scale; UPDRS-III – Unified Parkinson’s disease Rating Scale part III. 
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Group comparisons 
We conducted two sets of group comparisons: (1) a pooled analysis with 136 life partners, 
which is presented below, and (2) separate analyses with participants recruited via route 1 
(n = 57 spouses) and route 2 (n = 79), which is available as a supplementary file. 
 
Burden, stress and resilience 
A one-way ANOVA revealed that spouses of people with PDD and DLB experienced more 
burden and resentment than spouses of people with PD-MCI (both p < .05) (Table 6). In 
addition, spouses of people with PDD experienced, higher stress levels (p = .019), and less 
positive interaction with the care recipient (p = .018) compared to spouses of people with 
PD-MCI, but these variables did not differ between DLB and PD-MCI groups. The FCR-
satisfaction sub-scale failed the assumptions of ANOVA, thus we applied a Kruskal-Wallis H 
test, which revealed no statistical differences between the disease groups (p > .05). 
 
Weekly care provision hours did not differ among PD-MCI, PDD and DLB (p > .05); however, 
when PD-MCI was compared with the two dementia groups combined, spouses of people 
with PDD and DLB devoted more hours to caregiving each week (m = 102.59, SD = 60.72) 
than spouses of people with PD-MCI (m = 76.74, SD = 64.03) [t(133) = -2.16, p = .033]. 
Spouses of people with PDD provided care for longer than spouses of people with PD-MCI (p 
= .006) and DLB (p < .001), as determined by the Games-Howell post hoc test. 
 
Relationship satisfaction 
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Spouses of people with PDD had lower relationship satisfaction (p = .047) than spouses of 
people with PD-MCI, but we did not observe any statistically significant difference in 
relationship satisfaction between the PD-MCI and DLB groups. 
 
Health and quality of life 
Spouses of people with DLB had higher levels of anxiety (p = .010) and lower levels of 
mental health (p = .024) than spouses of people with PD-MCI but no difference was found 
between PDD and PD-MCI groups on these variables. Using a one-way ANOVA, we found a 
statistically significant difference in the HADS-depression scores among spouses of people 
with PD-MCI, PDD or DLB [F(2,133) = 9.94, p < .001]. Spouses of people with PDD and DLB 
had significantly higher depression scores than those caring for people with PD-MCI (both p 
< .001), as determined by the Games-Howell post hoc test. Finally, we found no statistically 
significant differences between PDD and DLB groups on any of the variables examined (p > 
.05). 
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Table 6 Spousal characteristics (n = 136) according to PD-MCI, PDD and DLB 
  ANOVA    Post hoc test 
  m (SD)  F P p 
Diagnosis PD-MCI  
(n = 37) 
PDD  
(n = 50) 
DLB  
(n = 49) 
 df  
(2,133) 
 PD-MCI 
vs PDD 
PD-MCI 
vs DLB 
Years caring 4.68 (3.35) 7.74 (5.62) 3.68 (3.43) 11.53 .000 .006‡ n.s. 
Hours caring pw 76.74 (64.03) 106.77 (63.15) 98.32 (58.48) 2.55 .082 n.s. n.s. 
RSS 28.68 (10.61) 22.48 (12.16) 24.22 (12.03) 3.07 .050 .047† n.s. 
ZBI 28.16 (14.19) 38.06 (14.00) 37.99 (16.78) 5.68 .004 .009† .011† 
BRS 3.60 (0.76) 3.51 (0.78) 3.47 (0.86) 0.31 .732 n.s. n.s. 
HADS-anxiety 5.73 (3.83) 7.88 (4.33) 8.65 (5.03) 4.69 .011 n.s. .010† 
HADS-depress. 3.46 (2.52) 6.46 (3.95) 6.96 (4.45) 9.94 .000 .000‡ .000‡ 
SF-12-PCS 51.96 (10.23) 49.10 (10.62) 50.49 (11.23) 0.76 .471 n.s. n.s. 
SF-12-MCS 48.28 (10.42) 44.87 (9.16) 42.28 (11.06) 3.63 .029 n.s. .024† 
EQ5D-index § 0.83 (0.19) 0.76 (0.24) 0.77 (0.19) 1.39 .253 n.s. n.s. 
EQ5D-VAS § 78.03 (14.97) 75.22 (17.95) 73.54 (16.39) 0.77 .465 n.s. n.s. 
Rel.SS 21.65 (9.59) 27.94 (10.85) 26.80 (10.77) 4.15 .018 .019† n.s. 
DRS-interaction 10.36 (3.57) 8.46 (3.03) 9.54 (2.87) 4.03 .020 .018† n.s. 
DRS-strain 4.38 (3.23) 6.04 (3.50) 5.64 (3.13) 2.85 .061 n.s. n.s. 
FCR-resentment 2.38 (0.80) 2.92 (0.97) 2.91 (1.03) 4.25 .016 .029† .035† 
FCR-anger 1.69 (0.73) 2.11 (0.86) 2.06 (0.83) 3.26 .042 n.s. n.s. 
Notes: † - Hockberg’s GT2 post hoc test; ‡ - Games-Howell post hoc test; §- winsorized.  
Abbreviations: ANOVA – analysis of variance; BRS – Brief Resilience Scale; df – degrees of freedom; DLB – 
Dementia with Lewy bodies; DRS – Dyadic Relationship Scale, positive interaction or negative strain sub-scale; 
EQ5D – EuroQoL-5D index or visual analogue scale (VAS); FCR – Family Caregiving Role scale; HADS – Hospital 
Anxiety and Depression Scale;  IQR – interquartile range; n.s. – not significant; PDD – Parkinson disease 
dementia; PD-MCI – Parkinson disease and mild cognitive impairment; pw – per week; Rel.SS – Relatives’ 
Stress Scale;  RSS – Relationship Satisfaction Scale; SD – standard deviation; SF-12 – Short Form 12 Health 
Survey, physical health (PCS) or mental health (MCS) sub-scale; ZBI – Zarit Burden Interview. 
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DISCUSSION 
Our study demonstrated that burden, stress, relationship dissatisfaction and feelings of 
resentment are common among spouses of people with PD-MCI, PDD or DLB. We also found 
that spouses of people with PDD and DLB have higher rates of burden, depression and 
feelings of resentment, compared to spouses of people with PD-MCI. Furthermore, spouses 
of people with PDD report higher levels of stress and lower levels of relationship 
satisfaction, whereas spouses of people with DLB exhibit higher levels of anxiety and lower 
levels of mental health, in comparison to PD-MCI. The daily care provision hours exceeded 
14 hours for over half of spouses in the current study, which is significantly higher than the 
level found in carers of people with dementia (i.e. between 3 and 11 hours per day).61 This 
finding highlights the complexity of PD-related dementias as well as an immense 
commitment by carers in taking care of their relatives. 
 
Several findings resonate with previous studies in terms of high levels of burden and stress, 
9,23,24,31,62 but relationship dissatisfaction, perceived negative feelings (resentment) and 
resilience are new findings emerging from this study, despite being well-researched 
constructs in carers of people with non-PD type dementia.63–67  This could be explained by a 
number of reasons. Firstly, people with PD-MCI, PDD or DLB have higher rates of 
burden,30,68 stress,32,33 depression,69 lower ability to live well,70 and more tension and 
arguments in the dyadic relationship71  compared to carers of people with Alzheimer disease 
and/or vascular dementia. Secondly, most carers are older adults themselves and many 
have physical or mental health problems,2 which makes caring for a relative increasingly 
demanding whilst also taking care of oneself. Thirdly, the new findings in regards to 
relationship dissatisfaction, feelings of resentment, and resilience in this study could be 
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explained by the use of the scales (i.e. RSS, FCR and BRS, respectively), which were generic, 
condition-neutral and which have not been used in this population before. For this reason 
we undertook psychometric property testing of these scales, which would act as a guidance 
to future studies in regards to selecting an appropriate measure in this population (reported 
in Vatter et al., in submission). Furthermore, the constructs of relationship satisfaction and 
resilience are both multi-faceted, complex and lack clear definitions which add additional 
complexities into the measurement process. Future studies should focus on examining the 
constituent parts, either through factors derived from a factor/cluster analysis of the 
measurements, or develop validated condition-specific scales de novo. 
 
Notwithstanding the high prevalence of burden, stress and low levels of mental health, 
many spouses in the current study had good quality of life and resilience, emphasising their 
ability to cope and adjust to the challenging nature of the care recipients’ condition. These 
findings are consistent with a recent qualitative study of spouses of people with PD-MCI, 
PDD or DLB72 where spouses had learned to accept and adapt to their partners’ condition 
despite the demands and stresses they faced. Importantly, however, in this study female 
spouses reported that they cherished their marital vows and exhibited commitment to 
support their partners ‘in health and in sickness’.72 Care provision frequently takes place 
within a long-term intimate relationship, and having a good relationship quality is important 
as it can protect against stressors and support carers’ quality of life;32,73 therefore, 
strengthening and supporting interpersonal relationships is crucial and should be a focus of 
future studies. 
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The finding that spouses of people with DLB had high levels of anxiety and poor mental 
health is novel despite comparative studies demonstrating that these carers have 
significantly more burden30 and stress32,33 compared to carers of people with other types of 
dementia. The impact of DLB on spouses may be more profound as the speed of onset of 
the condition is faster, the intensity of symptoms and levels of fluctuation are often higher, 
and impairments in certain areas of cognitive functioning greater than in PDD.74,75 
Interestingly, our study found that burden, stress, resilience, relationship satisfaction, 
quality of life, anxiety, depression and mental health levels did not differ between spouses 
of people with PDD and DLB. These findings suggest that both PDD and DLB appear to have 
a similar effect on spouses, which could be due to the two syndromes having a clinically 
similar symptom presentation in terms of cognitive, psychiatric and motor symptoms as well 
as share underlying pathology.11,13-18 However, further studies are required to determine 
the impact of PDD and DLB on spouses.   
 
The limitations of the study should be acknowledged. We were unable to elicit the disease-
specific aspects, such as motor, psychiatric and cognitive symptoms of PD for all care 
recipients due to the nature of the postal questionnaire, which precluded a wider 
exploration of the impact of disease-specific aspects on spouses. We were also not able to 
capture spouses’ health history and these data could have expanded our knowledge 
regarding the role that their physical and mental health needs played in their ability to 
provide care to their relatives. We also acknowledge the two different modes of 
administering the questionnaires as the data were combined from participants recruited 
through the INVEST study, where a researcher was present to help with any queries, and the 
postal questionnaire study, where participants self-completed the measures. This may have 
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influenced our results to a small extent. Furthermore, participants in the postal 
questionnaire had a self-selection bias as they chose whether to take part in the study or 
not. This bias would not have been as marked had we recruited all participants through a 
single route. Lastly, all information provided by spouses was subjective in nature and could 
have been biased or over-/underestimated depending on how spouses felt at the time of 
the assessments. Applying a longitudinal design could potentially extend our knowledge 
regarding spousal characteristics. 
 
CONCLUSION 
This is the first and largest study to date describing and comparing the characteristics of 
spouses of people with PD-MCI, PDD or DLB. Importantly, our study highlighted that spouses 
of people with PDD and DLB have high rates of burden, stress, relationship dissatisfaction 
and resentment as well as poor levels of mental health. A diagnosis of PDD and DLB should 
alert the clinician to the risk of carer burden, strain and stress and clinical symptoms, such 
as depression and anxiety, which will have implications for patient outcomes.   
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